MIST logo

Milestone Pharmaceuticals Inc. Common Shares


MIST: Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT.


Show MIST Financials

Consumer Interest
SEC Filings

Recent trades of MIST by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by MIST's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of MIST in WallStreetBets Daily Discussion


Recent insights relating to MIST

CNBC Recommendations

Recent picks made for MIST stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in MIST

Corporate Flights

Flights by private jets registered to MIST